Bringing structure and safety to the burgeoning peptide category, Protocole has closed a $6.0M Seed round. The modern peptide platform aims to streamline access to personalized peptide therapies, an area of health experiencing rapid growth but often lacking standardized oversight.
Protocole achieves this through a vertically integrated member experience that combines telemedicine, physician-guided access, and regulated pharmacy fulfillment. Its approach emphasizes personalized protocols, ensuring a more controlled and secure pathway for individuals seeking peptide treatments.












